UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Perigon Wealth Management LLC

Perigon Wealth Management LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 29.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,614 shares of the healthcare conglomerate’s stock after buying an additional 3,969 shares during the period. Perigon Wealth Management LLC’s holdings in UnitedHealth Group were worth $8,993,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the business. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group in the third quarter valued at approximately $27,000. Global Wealth Strategies & Associates boosted its stake in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC acquired a new position in UnitedHealth Group in the third quarter valued at $32,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $30,000. Finally, RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $37,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Down 0.2 %

Shares of UNH stock opened at $542.52 on Wednesday. The company has a market capitalization of $499.27 billion, a price-to-earnings ratio of 35.00, a PEG ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a 50-day moving average price of $540.11 and a 200 day moving average price of $565.06.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.83 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on UNH shares. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Truist Financial dropped their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. KeyCorp reiterated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.